Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a new release of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe ClinicalTrials.gov page footer/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a software release rather than a change to the study history details.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated to v3.5.0 (replacing v3.4.3) in the record history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page history now shows Revision: v3.4.3 as the latest update, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check95 days agoChange DetectedThe history list now includes a new revision entry: Revision: v3.4.2. The previously displayed funding-status notice and the v3.4.1 revision entry were removed.SummaryDifference0.3%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.